In summary, the small molecules induced degradation of BTK, CDK4/6, BCR-ABL and BRAF in cancer cells had a better anti-tumor cell proliferation effect than simply inhibiting, and they also demonstrated promising power in overcoming tumor drug resistance. This evidence concerns the gene BTK and neoplasm.